MRK vs GILD
By Alex · Tickerpine
Merck & Co., Inc. vs Gilead Sciences, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | MRK | GILD |
|---|---|---|
| Price | $128.66 | $127.88 |
| Market cap | $317.77B | $158.77B |
| P/E ratio | 36.2 | 17.4 |
| ROE | 18.94% | 43.36% |
| Profit margin | 13.59% | 30.99% |
| Revenue growth | 4.90% | 4.40% |
| Dividend yield | 2.64% | 2.56% |
| Beta | 0.22 | 0.33 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
MRK vs GILD in plain English
- MRK is the bigger company — about 2.0× the market cap of GILD.
- GILD is cheaper on earnings (P/E 17.4 vs 36.2).
- GILD earns a higher return on equity (43% vs 19%).
- MRK is growing revenue faster (5% vs 4%).
- MRK has the higher dividend yield (2.64% vs 2.56%).
How would $1,000 have done in each?
MRK return calculator
See what $1,000 in Merck & Co., Inc. would be worth today.
GILD return calculator
See what $1,000 in Gilead Sciences, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.